Ledger.Open graph →
SEC Form D · filed April 16, 2024

Asher Biotherapeutics, Inc

Offering
$55.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Craig Gibbs · South San Francisco, CAExec · DirectorIvana Djuretic · South San Francisco, CAExec · DirectorJeffrey Tong · Boston, MADirectorReid Huber · Boston, MADirectorKyle Elrod · South San Francisco, CAExecBob Deresiewicz · SOUTH SAN FRANCISCO, CADirectorElaine Sun · San Diego, CADirectorAndy Yeung · SOUTH SAN FRANCISCO, CAExecDon O'Sullivan · SOUTH SAN FRANCISCO, CAExecIan Clark · Tuckahoe, NYDirectorCraig Gibbs · South San Francisco, CAExec · DirectorIvana Djuretic · South San Francisco, CAExec · DirectorJeffrey Tong · Boston, MADirectorReid Huber · Boston, MADirectorKyle Elrod · South San Francisco, CAExecBob Deresiewicz · SOUTH SAN FRANCISCO, CADirectorElaine Sun · San Diego, CADirectorAndy Yeung · SOUTH SAN FRANCISCO, CAExecDon O'Sullivan · SOUTH SAN FRANCISCO, CAExecIan Clark · New Rochelle, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗